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ABSTRACT
This article reviews the current legislative requirements for risk assessment of combined exposure to
multiple chemicals via multiple exposure routes, focusing on human health and particularly on food-
related chemicals. The aim is to identify regulatory needs and current approaches for this type of risk
assessment as well as challenges of the implementation of appropriate and harmonized guidance at
international level. It provides an overview of the current legal requirements in the European Union
(EU), the United States and Canada. Substantial differences were identified in the legal requirements
for risk assessment of combined exposure to multiple chemicals and its implementation between EU
and non-EU countries and across several regulatory sectors. Frameworks currently proposed and in use
for assessing risks from combined exposure to multiple chemicals via multiple routes and different
durations of exposure are summarized. In order to avoid significant discrepancies between regulatory
sectors or countries, the approach for assessing risks of combined exposure should be based on similar
principles for all types of chemicals. OECD and EFSA identified the development of harmonized meth-
odologies for combined exposure to multiple chemicals as a key priority area. The Horizon 2020 project
“EuroMix” aims to contribute to the further development of internationally harmonized approaches for
such risk assessments by the development of an integrated test strategy using in vitro and in silico
tests verified for chemical mixtures based on more appropriate data on potential combined effects.
These approaches and testing strategies should be integrated in a scientifically based weight of
evidence approach to account for complexity and uncertainty, to improve risk assessment.
ARTICLE HISTORY
Received 8 August 2018
Revised 17 October 2018
Accepted 24 October 2018
KEYWORDS
Cumulative risk assessment;
chemical mixtures;
pesticides; combined
exposure; dietary exposure;
harmonization; testing
strategies; policy making
1. Introduction
Chemical risk assessments are performed to ensure the pro-
tection of human and environmental health. Traditionally, risk
assessments are conducted on an individual chemical basis,
mostly addressing one source of exposure (single chemical
and one route of exposure). However, the human population
and the environment are continuously exposed to a multi-
tude of substances from different sources via different routes
and duration of exposure, as has been demonstrated in
environmental (Malaj et al. 2014; Wu et al. 2014; Maruya
et al. 2016) and human monitoring (Woodruff et al. 2011;
CDC 2018) studies. Exposure to multiple chemicals may
increase health risks, relative to those of individual chemicals,
due to potential combined effects, exhibited via similar or
dissimilar mechanisms. Due to the large number of chemicals
present in the environment, risk assessment of chemical com-
binations is complex and poses a number of challenges for
scientists, risk assessors and managers (EFSA 2016). Increasing
awareness that in daily-life exposure is to mixtures of chemi-
cals, needing a move beyond chemical-by-chemical assess-
ments, has led to a prioritization of this topic in policy and
research. There are a number of different possible scenarios
that need to be addressed. These include products containing
more than one defined chemical component (intentional mix-
tures), products comprising a complex mixture of chemicals,
not all of which are defined (intentional mixtures of Unknown
or Variable composition, Complex reaction products or
Biological materials, UVCBs), and exposure to multiple chemi-
cals from different products (incidental or unintentional mix-
tures). An agreed and sufficiently specific and applicable
technical guidance is needed to facilitate a consistent and
adequate implementation of a harmonized approach for risk
assessment of combined exposure to multiple chemicals via
multiple routes (Solecki et al. 2014). Various frameworks on
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this type of risk assessment have been proposed or are
actively being developed by European or international organi-
sations, such as the European Food Safety Authority (EFSA),
the World Health Organisation (WHO), the International
Programme on Chemical Safety (IPCS) and the Organisation
for Economic Cooperation and Development (OECD)
(reviewed in Kienzler et al. 2016). Several EU research projects
focusing on different aspects on combined exposure to mul-
tiple chemicals are ongoing or have recently been finished at
the date of this publication (Bopp et al. 2018).
Contributing to the further development of internationally
harmonized approaches for human health risk assessment of
combined exposures to multiple chemicals is the overall goal
of the Horizon 2020 project “EuroMix” (European Test and
Risk Assessment Strategies for Mixtures; www.euromixproject.
eu). More specifically, EuroMix aims to establish efficient and
verified testing and tiered assessment strategies for mixtures
of chemicals, including the appropriate test methods and
tools. In line with existing approaches for risk assessment of
combined exposure to multiple chemicals, the strategies
being developed within the EuroMix project are mechanism-
based. In the EuroMix project, in principle all chemical classes
(cumulative) and all routes (aggregate) of combined exposure
are considered for their effects on human health. However,
this article focuses mainly on food-related chemicals such as
plant protection products, biocidal products and their resi-
dues, food and feed additives, and contaminants, i.e. chemi-
cals to which humans are potentially exposed via the diet.
The aim of this manuscript is to identify regulatory differen-
ces and current challenges in the implementation of risk
assessment of combined exposure to multiple chemicals and
to outline how EuroMix could contribute to the development
of new approaches and testing strategies for this type of risk
assessment. To that end, the current legislative requirements
were reviewed, focusing on human health and particularly on
food-related chemicals. An overview is provided of the current
legal requirements for assessing the risk to human health from
exposure to multiple chemicals in the European Union (EU),
the United States (US) and Canada (Section 2). Additionally,
this manuscript summarizes general principles, frameworks cur-
rently proposed and in-use for risk assessment of combined
exposure to multiple chemicals (Section 3). Building on this,
the EuroMix contribution to the development of new
approaches and testing strategies for such risk assessment is
summarized (Section 4). Finally, it outlines challenges in the
approaches and testing strategies for risk assessment of com-
bined exposure to multiple chemicals and provides recommen-
dations with regard to international harmonization (Section 5).
It should be noted that in this manuscript the term “risk
assessment of combined exposure to multiple chemicals”
refers to assessing the combined risk from exposure to mul-
tiple chemicals with similar or dissimilar modes of action, via
different routes of exposure, with exposure being defined
according to the WHO/IPCS workshop on cumulative risk
assessment (WHO 2009), i.e. “exposure via all relevant routes
and pathways, including concurrent exposures to multiple
chemicals or where exposure at different times leads to over-
lap in the time course of effects as a consequence of their
respective toxicokinetics and/or toxicodynamics”. The key
terms are based on previous initiatives for harmonized ter-
minology of WHO/IPCS (WHO 2009) and EFSA (EFSA 2013a).
2. Legal requirements for risk assessment
of mixtures
This section provides an overview of the current legal
requirements for risk assessment of combined exposure to
multiple chemicals in the EU and describes legal frameworks
in the US and Canada. A brief outline on all reviewed legal
acts is presented in Table 1.
2.1. European Union
Within the EU, the placing of chemical substances and prod-
ucts on the market is highly regulated in order to ensure a
high level of protection for human health. For the registra-
tion, evaluation, authorization and restriction of chemicals
(REACH) within the scope of Regulation EC (2006), all obliga-
tions are related to substances (i.e. products of manufactur-
ing processes) and no separate requirements or guidance for
the hazard and risk assessment of combined exposure to
multiple chemicals is provided (Kortenkamp et al. 2009;
CEFIC 2010). The REACH guidance document addresses
aggregate exposure of single substances for consumers
(ECHA 2016). In contrast, clear criteria for classification of
both substances and intentional mixtures (i.e. products that,
as marketed, contain more than one chemical substance) are
laid down in the Classification, Labelling and Packaging (CLP)
Regulation (EC 2008a), where “available information on syner-
gistic and antagonistic effects should be taken into account for
the classification of mixtures” (Recital 37). The CLP Regulation
provides guidance on the hazard classification of such chem-
ical mixtures and proposes four classification methods,
depending on the available data and on the properties of
the components of the mixture (ECHA 2017).
Plant Protection Products (PPP) and Biocidal Products (BP)
are intentional mixtures, comprising technical formulations
with known composition of one or more pesticidal active
substance(s) and additional components (e.g. solvents, emul-
sifiers). They are regulated under different legal acts, based
on their intended use. For the authorization of PPPs and BPs,
active substances therein need to be approved (EC 2009; EU
2012). The Regulation on BPs (EU 2012) explicitly requires
cumulative and synergistic effects (presumably of substances
present in the product, but this is not stated explicitly) be
taken into account. Furthermore, the BP Regulation even stip-
ulates collaboration between Agencies, Member States and
the European Commission to develop and provide guidance
on the scientific definitions and methodologies for the
assessment of cumulative and synergistic effects. The
European Chemicals Agency (ECHA) provides guidance to
account for risks exerted by multiple substances within a sin-
gle BP (ECHA 2015). With regard to the authorization of PPPs,
sufficient information to allow for a cumulative risk assess-
ment, considering exposure to more than one chemical sub-
stance, is required for pesticidal active substances and co-
formulants contained in the product (EU 2013a, 2013b). This
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information is required to evaluate whether PPPs and their
residues may have harmful effects on human health, whereby
“known cumulative and synergistic effects where the scientific
methods accepted by the Authority to assess such effects are
available”, shall be taken into account (EC 2009, Article 4). In
the authorization procedure of PPPs, interactions between
active substances and other components of the PPP shall be
taken into account (EC 2009, Article 29). No harmonized
guidance on the implementation of the assessment of com-
bined exposure to multiple PPPs exists, but approaches for
operators and consumers were proposed by Stein et al.
(2014). Recently, the Group of Chief Scientific Advisors
advised the European Commission (EC 2018) that “The PPP
approval and authorisation process must better assess risks
associated with PPP mixtures and long-term exposure”. Many
activities regarding assessment of combined exposures and
combined effects are based on the Regulation defining the
setting of limit values for residues in food and feed products
(EC 2005), designated as Maximum Residue Levels (MRLs).
The MRL regulation clearly requires the development of
methodologies for risk assessment of combined exposures to
chemicals from multiple products, i.e. incidental mixtures, in
order to account for “[… ] pesticide residues arising from sour-
ces other than current plant protection uses of active substan-
ces, and their known cumulative and synergistic effects, when
appropriate methods are available” (EC 2005, Article 14).
Furthermore, the MRL Regulation addresses measures for fur-
ther development of legislation and technical guidelines on
pesticide residues for the assessment of aggregated, cumula-
tive and synergistic effects. This requirement is fundamental
in the assessment of potential combined effects, as in many
pieces of EU legislation this task is conditional on the avail-
ability of appropriate methods. Official guidance would be
the first step to enable a sound product and consumer-based
risk assessment of combined exposures to multiple chemicals
via different routes of exposure.
General principles and requirements for food safety are
regulated by the European Food Law (EC 2002), requiring that
unsafe food shall not be placed on the market, which includes,
amongst others, the determination of whether potential
Table 1. Overview of the chemical and mixture assessment requirements for intentional mixtures in the legislation of EU, US and Canada.
Description of the reviewed legislation
Mixture assessment for human
health required?
Guidance document for cumulative risk
assessment available?
A) European Union
Industrial chemical related regulations
REACH Regulation (EC) 1907/2006 No1mixture assessment, but consider-
ation of cumulative exposure in
ECHA (2012)2
No
CLP Regulation (EC) 1272/2008 Yes, defined classification criteria
for mixtures.
ECHA (2017)
Pesticide related regulations
Plant protection products and data
requirements
Regulation (EC) 1107/2009 Yes, for the constituents of the product.
No consideration for mixture assess-
ment from different sources.
No
Regulation (EU) 283/2013
Regulation (EU) 284/2013
Biocidal products Regulation (EU) 528/2012 Yes, for the individual components of
the product and if the biocidal prod-
uct is intended to be authorized for
use with other biocidal products.
ECHA (2015)
MRLs Regulation (EC) 396/2005 Yes, for pesticide residues from pesti-
cide uses and other sources.
No
Dietary exposure related regulations
Food law Regulation (EC) 178/2002 Yes, cumulative toxic effects for food
shall be considered.
No
Food additives Regulation (EC) 1333/2008 No No
Additives for use in animal nutrition Regulation (EC) 1831/2003 No No
Feed additives Regulation (EC) 429/2008 No No
B) United States
Pesticides Food Quality Protection Act
(FQPA), 1996
Yes US EPA (2002a, 2016a)
Food additives; New animal drugs;
Color additives
Federal Food, Drug, and Cosmetic Act
(FFDCA 2018)
No No
Environmental Pollutants No legal mandate Yes US EPA (2000, 2003b)
C) Canada
Pesticides Pest Control Products Act (PCPA 2018) Yes [Harmonisation with US EPA]
Environmental Pollutants Canadian Environmental Protection Act
(CEPA 1999)
Yes Health Canada (2010a, 2010b)
CLP: Classification, Labelling and Packaging of substances; EC: European Commission; ECHA: The European Chemicals Agency; EU: European Union; US EPA:
United States – Environmental Protection Agency; REACH: registration, evaluation, authorization and restriction of chemicals; MRL: maximum residue levels.
1No mixture assessment of different substances required. The definition of substances under REACH includes impurities and additives necessary for stability.
2“The relevant exposure parameter (mean level, peak level, duration, cumulative dose) depends on the health outcome and exposure setting and should be justi-
fied. [… ] In many epidemiological studies, in particular occupational studies, cumulative exposure (cumulative exposure¼ exposure level  exposure duration,
e.g. ppm years) is used as exposure metric.”
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cumulative exposure might be injurious to health (Article 14).
No further explanation for the implementation of this require-
ment is provided, even though the Food Law provides the
legal basis for more specific legislation such as for food and
feed additives. No specific legal requirements for evaluating
combined exposures and combined effects are laid down in
the current Regulation on food additives (EC 2008b) or on
feed additives (EC 2003). However, the implementing
Regulation on feed additives (EC 2008c) requires a separate
assessment of each component and the consideration of the
cumulative effect for consumer safety or the assessment of the
complete (intentional) mixture. No further guidance on the
implementation of combined effect assessments is provided.
Most of the reviewed European Regulations stipulate the
need to consider potential combined effects from exposures
to multiple chemicals within intentional mixtures of different
components within formulated products. As the development
of guidance in response to these mandates is still pending,
current legal requirements regarding the assessment of risks
of combined exposure to multiple chemicals are often condi-
tional to statements like “where relevant” or “known and
expected cumulative and synergistic effects shall be considered”.
This leads to ambiguity in the consideration of mixture tox-
icity (i.e. combined effects) that depends on interpretation of
the different regulations, expert knowledge and the public
availability of toxicity data. Regardless, however, implementa-
tion of clear legal mandates in regulations to assess the com-
bined effects of substances in products or of different
products, will be difficult as long as harmonized and
accepted methods are lacking.
2.2. United States and Canada
In general, legislative mandates give the US Environmental
Protection Agency (US EPA) broad authority to protect public
health in allowing the use of cumulative risk or chemical mix-
tures assessment in decision-making. For the risk assessment
of pesticides, the Federal Food, Drug, and Cosmetic Act
(FFDCA 2018) and the Food Quality Protection Act (FQPA
1996) mandate US EPA to consider, among others, cumula-
tive exposure to different pesticides that have been shown
to have common mechanisms of toxicity and aggregate
exposure to one pesticide from multiple sources of exposure
(food, water, residential and other non-occupational sources).
The legislative requirements set by FFDCA (2018) and FQPA
(1996) are addressed in several guidance documents (US EPA
1999, 2001, 2002a, 2002b, 2016a). The US EPA has adopted a
tiered approach for cumulative risk assessment that begins
with a screening level analysis using conservative hazard and
exposure assumptions based on the level of scope and
refinement needed (US EPA 2016a). Besides pesticides, the
FFDCA (2018) also mandates US Food and Drug
Administration (FDA) to consider cumulative effects in the
process of regulating food additives, new animal drugs and
color additives. However, no specific guidance has been
developed for these chemical classes. Since this process may
be hindered by limited data availability, US EPA (2000) rec-
ommends following both a component and a whole mixture
based risk assessment approach, giving rise to an integrated
summary and uncertainty evaluation.
In Canada, pesticides are regulated by the Pest
Management Regulatory Agency (PMRA) of Health Canada,
under the Pest Control Products Act (PCPA 2018) and
Regulations made under this Act. In the PCPA there is a clear
mandate to consider aggregate exposure from diet and resi-
dential sources and cumulative effects of pest control and
other products that have a common mechanism of toxicity in
the process of human health risk assessment. In order to meet
this legislative requirement, PMRA is harmonizing with US EPA
approaches. As in the US, under the Chemicals Management
Plan, Health Canada, Environment Canada and Climate Change
Canada have also conducted several risk assessments on inci-
dental mixtures using various approaches including moiety
based approaches (metal-containing chemical groups), whole
mixture based approaches and component-based approaches
(phthalates). Under the Canadian Environmental Protection Act
(CEPA 1999), Health Canada has developed guidance docu-
ments (Health Canada 2010a, 2010b) on human health risks
posed by combined exposures from federal contaminated sites
under the Federal Contaminated Sites Action Plan.
Overall, in the US and Canada there are legal mandates
for cumulative risk assessment of intentional mixtures and for
incidental mixtures occurring in a number of different scen-
arios. These mandates are addressed in specific approaches
described in relevant guidance documents, which are imple-
mented as part of the regulatory processes.
2.3. Regulatory needs
Current legislative frameworks within the EU, the US and
Canada highlight the need to assess potential combined
effects from exposure to multiple chemicals. However, sub-
stantial differences were identified in the legal requirements
for risk assessment of combined exposure to multiple chemi-
cals and its implementation between the countries and regu-
latory sectors (silos) approving different groups and intended
uses of the chemicals reviewed. Whereas in the US and
Canada, guidance and risk assessments of combined expos-
ure to multiple pesticides have been advanced, in the EU
suitable approaches for this are still under development.
Although there are legal mandates regarding risk assessment
of combined exposure to multiple chemicals, cumulative risk
assessment has been considered in various ways across
authorities and organizations. Thus, a bottleneck appears to
be the lack of available and accepted scientific methods and
harmonized approaches to provide guidelines on how to
assess and evaluate combined adverse effects from exposure
to multiple chemicals. This type of risk assessment conducted
in different countries and under different regulatory frame-
works should be based on similar principles in order to avoid
significant discrepancies between regulatory sectors or coun-
tries. Thus, harmonized and clearly structured frameworks,
which lead risk assessors through the process of assessing
risks of combined exposures to multiple chemicals, are
required. This would be facilitated by setting up a network
involving European and Non-European authorities and
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international organizations such as EFSA, Joint Research
Center (JRC), OECD, WHO, and US EPA to generate synergies
and combine efforts to develop harmonized approaches.
3. Existing frameworks for health risk assessment of
chemical mixtures
As indicated in Section 2, most regulatory authorities and
organizations require some assessment of human health risks
associated with combined exposure to multiple chemicals,
whereas only a few propose and use existing frameworks.
Table 2 provides a structured overview and comparison of 14
frameworks identified for review, in terms of the scope, pur-
pose and some general principles applied. These frameworks
have been developed by different organizations under differ-
ent jurisdictions and regulatory settings. Some are meant to
be general approaches applicable for different purposes (e.g.
EFSA 2018a focused on the food and feed safety areas, but
can be broadened to other regulatory areas and across regu-
latory sectors), while others have been developed for assess-
ment of chemical mixtures from a specific exposure source
(e.g. ATSDR 2018) or belonging to a group of chemicals with
a specific use and/or regulated under product-specific legisla-
tion (e.g. US EPA 2002b; EFSA 2008; Stein et al. 2014; ECHA
2015; US EPA 2016a). Although, the purpose, scope, consider-
ations for problem formulation and principles applied vary to
some extent between the existing frameworks, they also
show many similarities. EFSA has previously conducted a
review to summarize the terminology, methodologies and
frameworks developed by national and international agencies
and to provide recommendations for future activities at EFSA
in this area (EFSA 2013a). Some additional frameworks have
been presented by the German Federal Institute for Risk
Assessment (Stein et al. 2014), ECHA (2015), the European
Chemical Industry Council, CEFIC (Price et al. 2012) and the
Health and Environmental Sciences Institute (HESI) (Moretto
et al. 2017), as well as an updated approach from the US
Agency for Toxic Substances and Disease Registry
(ATSDR 2018).
EFSA evaluated available scientific principles and frame-
works for the assessment of human health risks associated
with combined exposure to multiple chemicals. Based on
this, EFSA developed a flexible overarching framework for
human, animal and ecological mixture risk assessment, which
was recently published as a draft guidance document (EFSA
2018a). Therein, EFSA proposes harmonized risk assessment
methodologies for combined exposure to multiple chemicals
and describes tiered and stepwise approaches for all tiers of
the risk assessment. Peculiarities related to genotoxicity
assessment of chemical mixtures are addressed in a specific
EFSA statement (EFSA 2018b).
The frameworks reviewed here commonly take the form
of decision trees or tiered processes, or a combination of the
two. In this context, decision trees provide stepwise guidance
for how to proceed through the risk assessment process
based on conclusions regarding, for example, the hazard or
data availability in previous steps. The US EPA presents an
example of such a decision tree (US EPA 2000, 2002b) and
the Scientific Steering Committee of the Norwegian Scientific
Committee for Food Safety proposes a step-by-step approach
for the risk assessment of multiple chemical exposures (VKM
2008). In tiered frameworks, assessment is described as being
conducted in phases, with conservative risk assessments
based on deterministic worst case scenarios and default esti-
mates of exposure and hazard at the lower (first) tiers and
with each consecutive tier being more refined, i.e. less uncer-
tain, than the previous one. The WHO/IPCS tiered framework
for the risk assessment of combined exposure to multiple
chemicals (Meek et al. 2011) is well recognized and has been
applied and adapted by several other organizations for their
purposes, for example by the scientific committees of the
European Commission (SCHER/SCENIHR/SCCS 2012), CEFIC
(Price et al. 2012) and ECHA (2015). The CEFIC framework fur-
ther provides an example of a combination of a decision tree
and tiered process.
Risk assessment of combined exposures to multiple chem-
icals via different routes of exposure may be based on expos-
ure and hazard data of the whole mixture or, alternatively,
on data for the individual components. With the exception of
the early guidance from US EPA (2000), which states that a
whole mixture approach is generally preferred, a component-
based approach, where feasible, seems to be generally
accepted as the most appropriate approach for a great num-
ber of mixture risk assessments. The US Agency for Toxic
Substances and Disease Registry (ATSDR 2018) and EFSA
(2018a) recognize that a whole mixture approach may be
applied where feasible and depending on the problem for-
mulation of the assessment. While a whole mixture approach
may be useful, or indeed necessary, if data are available only
on the specific mixture, it is only applicable when exposure
is from a single source and for mixtures that do not change
significantly in their composition (Price et al. 2012; SCHER/
SCENIHR/SCCS 2012). Whole mixture assessments are limited
to the endpoints that can be measured in toxicity studies of
that mixture. A stepwise application of both approaches
might be appropriate for specific assessments.
Structured, tiered frameworks, as well as basic methodolo-
gies, have been developed, proposed and thoroughly dis-
cussed by several organizations. However, often the lack of
agreed and sufficiently specific and applicable technical guid-
ance is the major obstacle for a consistent and adequate
implementation of mixture risk assessment (Solecki
et al. 2014).
3.1. Deterministic and probabilistic assessment
A common theme in tiered frameworks for assessing risks
from combined exposure to multiple chemicals is to apply a
deterministic approach to generate conservative estimates of
risk at lower tiers, and consequently refine the assessment if
needed at higher tiers. As the level of complexity in the
assessment is increased, estimates of risk become more real-
istic but more laborious with higher data requirements. The
EFSA (2008), WHO/IPCS (Meek et al. 2011), HESI (Moretto
et al. 2017), and ATSDR (2018) frameworks, for example, pro-
vide descriptions of data needs and specific approaches at
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different tiers. For exposure, low tier assessment may be
based e.g. on information on sale or use patterns or on MRLs
in the case of pesticides to provide worst case conservative
exposure estimates for the mixture. At higher tiers, determin-
istic exposure estimates may be derived by using point esti-
mates of high and mean values from measured data, e.g.
from monitoring programs, and modeling data for food con-
sumption. Deterministic exposure assessments may be further
refined, e.g. for different groups of the population or by
using physiologically based pharmacokinetic (PBPK) modeling
to estimate internal exposure levels. The assessment of a
realistic exposure of humans and the environment to certain
chemicals is a major challenge as different exposure routes
have to be considered and the total exposure has to be
assessed. However, extensive monitoring data for an expos-
ure are rarely available.
At the highest tiers, probabilistic exposure assessment
may be conducted. In this approach, exposure to chemical
mixtures in food is based on distributions of the concentra-
tions of mixture components in different food items, as well
as on distributions of the consumption of these foods in the
population or in specific population groups. This allows con-
clusions to be drawn about, for example, the distribution of
exposure levels in the population to different mixture com-
ponents and the proportion of the population that may be
at risk of exceeding specific exposure levels. Practical exam-
ples of integrated probabilistic cumulative risk assessments
for exposures to organophosphorus and anti-androgenic pes-
ticides as well as organophosphorus and carbamate insecti-
cides in the Dutch population are shown in Boon et al.
(2008), Bosgra et al. (2009), and M€uller et al. (2009). Basic
probabilistic methodology for modeling dietary exposure to
pesticide residues has been described by the EFSA (2012).
Van der Voet et al. (2015) proposed the implementation of
the more advanced software system MCRA in the EFSA guid-
ance and gave example calculations on the triazole group.
The potential of this model is illustrated in case studies for
different population groups in country-specific scenarios
(Kennedy et al. 2015). Recently, probabilistic modeling is
gaining recognition as an approach to exposure assessment,
which is reflected in Europe by discussions between the
European Commission and EFSA on the implementation of
two probabilistic tiers for assessing risks from combined
exposure to multiple chemicals. The degree of refinement of
the estimates used at the start of the assessment (i.e. which
tier) is determined by a number of factors, such as data avail-
ability, resources required, urgency of the assessment, and
hence should be part of problem formulation.
Analogously, hazard assessment at the lowest tier may be
based on the worst-case assumption that all components in
the mixture or assessment group have the same potency for
inducing adverse health effects as the most toxic component
in a dose additive manner. The lowest health-based guidance
value, such as an acceptable daily intake (ADI), even if not
based on the common effect, identified among the compo-
nents can be used as a conservative basis for risk estimations
at the lowest tier. Deterministic hazard assessment may be
refined at higher tiers by using individual points of departure
for the common adverse effect (No Observed Adverse Effect
Levels (NOAELs) or Benchmark Doses (BMDs)) for each of the
components and relative potency factors (RPF) for this effect.
At the highest tier(s), assessment may be further refined by
use of dose-response data/models and PBPK modeling to
provide exposure estimates and thus probabilistic estimates
of hazard. Increasingly detailed information on the mecha-
nisms underlying toxicity (mode of action (MoA), adverse out-
come pathway (AOP)), if available, may be used to refine the
grouping of chemicals for which a risk assessment for com-
bined exposure to multiple chemicals is conducted.
The use of non-animal data, e.g. in vitro and in silico data,
in risk assessment of chemicals is becoming increasingly
more important with new advancements in such technolo-
gies and a general movement towards replacing, reducing
and refining animal studies in toxicity testing. The use of
non-animal data in the context of risk assessment of chemical
mixtures, e.g. for strategies for refined grouping or distin-
guishing between similar and dissimilar MoAs, remains to be
further explored.
3.2. Principles for grouping
Prioritisation and grouping have been specifically discussed
by EFSA (2013b) and US EPA (2002b, 2016a) and are gener-
ally addressed in several of the frameworks reviewed here.
There are two main factors influencing grouping: one is
exposure-based, i.e. the likelihood that the components may
co-occur, whereas the other is toxicity-based and relates to
similarity in toxicity, or the potential for interactions, between
components. To some extent, the choice of approach will be
determined by the regulatory requirement and problem for-
mulation of the assessment.
In early guidance from US EPA (2000), as well as in the
frameworks presented by the UK Interdepartmental Group on
Health Risks from Chemicals (IGHRC) (2009) and the WHO/
IPCS (Meek et al. 2011), on the “silo-less” assessment of
chemical mixtures, grouping was based first on co-exposure,
then on toxicological similarity. The ATSDR (2018) primarily
considers co-exposure, since this approach has been specific-
ally developed for assessment of exposure at sites of environ-
mental contamination. Consideration of similar toxicity is
included in the highest tier (Tier 3) in the ATSDR framework.
In general, in low tier assessments, estimations of co-
exposure could be based on information of use patterns. For
example, in the case of pesticides, if substances are expected
to be used on the same crops at the same time, or their resi-
dues are present in different commodities expected to be
consumed during the same time period. At higher tiers, real
data on consumption and pesticide residues from monitoring
data are used. Estimations of co-exposure may be refined for
different sub-groups and by the use of PBPK-modeling and/
or probabilistic approaches. In guidance from other organiza-
tions, including EFSA and ECHA, that covers groups of chemi-
cals for specific uses such as pesticides, co-exposure is not
specifically discussed as a factor for grouping in the hazard
assessment. In those cases, grouping is primarily based on
similar target organs and/or mode of action. Well-known
examples are EFSA’s cumulative assessment groups (CAGs)
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(EFSA 2013b). However, it should be noted that formation of
a CAG is not in itself a final risk assessment and it is not yet
clear whether and to what extent EFSA will take exposure
into account for this purpose.
EFSA’s approach for grouping pesticides into CAGs was
based on identifying pesticides that affect the same organ or
physiological system and exhibit similar toxicological proper-
ties (adverse outcome) in that organ or system (EFSA 2013b).
The methodology consists of four stages:
1. Identification of specific and unambiguous toxic effects
that adversely affect an organ or system - known as haz-
ard identification (e.g. effects on the thyroid system);
2. Hazard characterization that describes a specific adverse
effect to this organ or system (e.g. changes in hormone
levels reflecting effects on thyroid follicular cells);
3. Data collection – gathering data on the indicators (e.g.
changes in hormone levels at the dose where the
adverse effect occurs) that point to a specific toxic effect
(e.g. imbalance of the thyroid system) in an
organ/system;
4. Grouping of pesticides that exhibit a similar toxicological
effect into CAGs by organ/system and effect (e.g. thyroid
follicular cell toxicity).
To date, EFSA’s Panel on Plant Protection Products and
their Residues (PPR) have applied this methodology to define
groups of pesticides which are toxic to the thyroid and cen-
tral nervous systems. Currently, EFSA is conducting pilot
assessments of risks caused by multiple pesticides to con-
sumers, which are expected to be finalized by the end of
2018. A Monte Carlo Risk Assessment (MCRA) tool, developed
in close cooperation between EFSA and the Dutch National
Institute for Public Health and Environment (RIVM), is used to
examine combined effects on human nervous and thyroid
systems caused by exposure to pesticides in food
(EFSA 2018c).
The new EFSA guidance document (EFSA 2018a) describes
a flexible approach to the grouping of chemicals, depending
on problem formulation, based on
 Common regulatory domain
 Common source, environmental media
 Common functional group(s)
 Common constituents or chemical classes
 Common breakdown products
 Common “critical” target organ(s)
 Common MoA or AOP, similar toxicokinetics.
As more hazard data become available, risk assessors have
the option to refine the grouping of chemicals using weight
of evidence approaches, dosimetry (toxicokinetics) or mech-
anistic data such as MoA, AOP etc (EFSA 2018a).
US EPA considers also exposure data to group chemicals
into common mechanism groups (CMGs), on the basis that
not all chemicals, pathways of exposure (e.g. residential,
food, drinking water), or uses are risk contributors requiring
risk mitigation measures.
The methodology applied most often for specific pesticide
chemical groups (US EPA 2002b), involves:
1. Identification of CMGs, i.e. substances that cause a com-
mon toxic effect via similar sequence of major biochem-
ical events following the initial chemical interaction,
essentially the same MoA (US EPA 1999);
2. Performance of aggregate risk assessment for each
chemical in the CMG based on exposure data (US
EPA 2001);
3. Consideration of exposure data for refinement of the
CMGs to common assessment groups (US EPA 2002b).
US EPA has grouped a number of pesticides for the
assessment of risks from combined exposure. Potential mem-
bership of a CMG is based on similarities in chemical struc-
ture and pesticidal mode of action. To date, CMGs have
been created for: organophosphates, N-methyl carbamates,
chloracetanilides, triazines, naturally occurring pyrethrins and
synthetic pyrethroids. US EPA also examined thiocarbamates
and dithiocarbamates as potential CMGs, but determined
the available evidence did not support inclusion in a com-
mon mechanism group.
The US EPA developed a risk-based screening approach
for pesticides to supplement its existing guidance for estab-
lishing CMGs and conducting cumulative risk assessments
(US EPA 2016a). In case a common mechanism is not identi-
fied (Option 1), cumulative risk assessment is not warranted
(US EPA 2016a). Where there is limited evidence of common
toxicological profile a candidate CMG is identified (Option 2),
screening level toxicology and exposure analysis is applied,
where further data might be required on a case-by-case basis
(US EPA 2016a). An example of such a candidate CMG is the
avermectins (US EPA 2015, 2016b). A CMG can be estab-
lished, provided that sufficient evidence for a common toxi-
cological profile (based on detailed knowledge on toxicity
and exposure) is available (Option 3). Then problem formula-
tions determine the degree of scope and refinement needed.
It is important to note that assumptions used for grouping
contribute to the uncertainties in the assessment of chemical
mixtures, which have to be carefully considered and handled.
For example, uncertainties associated with:
1. Identification of relevant mixture components and the
assumptions made regarding whether MoA is similar or
dissimilar. In this regard, information on secondary
effects may often be especially inadequate;
2. Omissions from assessment groups due to lack of expos-
ure data (US EPA 2007) or lack of information about
chemicals, such as pesticides, present on the worldwide
market (EFSA 2013b);
3. The level of accuracy with which (co-)exposure to mix-
tures has been characterized, keeping in mind that
exposure estimates may be based on several sources/
uses and a number of events at several locations over
broad and varied time periods.
The fundamental problem for grouping is that it is not
possible to identify and assess all potential chemical
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mixtures. This makes the prioritization of chemicals for mix-
ture risk assessment, and the organization into relevant
assessment groups, central to the development and refine-
ment of methodologies in this area. The potential for expos-
ure and similar effects/MoA are key factors that should drive
prioritization, as well as grouping. However, there is a strong
need for development of approaches to further refine group-
ings, such as the EFSA CAGs, into narrower/smaller groups.
3.3. Dose addition as default assumption
There is general agreement between current frameworks that
dose addition should be used as the default assumption for
assessing risks from combined exposure to chemical compo-
nents with the same adverse outcome. Strictly speaking,
components should have a similar MoA for dose addition to
be applicable but, since mechanistic data commonly is lim-
ited, evidence of common target organ and effect is often
considered sufficient (US EPA 2000). It has also been shown
that dose addition may be appropriate in some cases where
mixture components act via different MoAs (discussed
below). Dose addition entails estimating the effect and cumu-
lative risks of the mixture from the sum of the doses/concen-
trations, scaled for the relative potency of the mixture
components. The most common approach for applying dose
addition is use of the hazard index (HI) methodology.
Refinements, using outcome- and exposure route specific
RPFs as well as PBPK-modeling are also discussed in many of
the current frameworks.
It is generally argued that if there is sufficient evidence to
show that components act independently, i.e. lead to the
same adverse outcome via completely dissimilar MoAs,
response or effect addition (concept of independent action)
is more appropriate than dose addition (SCHER/SCENIHR/
SCCS 2012). The EFSA PPR panel assessed the relevance of
dissimilar MoAs for risk assessment of combined exposure to
substances that produce a common adverse effect on the
same organ/system (EFSA 2013c). The panel concluded that
there was no case documented in the scientific literature
where independent action provided predictions that were
more conservative than dose addition for the effects of a
mixture of chemicals producing the same adverse outcome
and hence dose addition would be an appropriately conser-
vative default assumption. This approach is supported by
conclusions from other organizations (US EPA 2002b; EFSA
2008; IGHRC 2009; Meek et al. 2011; SCHER/SCENIHR/SCCS
2012; ATSDR 2018). EFSA’s PPR panel therefore recom-
mended also using dose addition for risk assessments of
combined exposure to mixtures of pesticides with dissimilar
MoAs, provided they produce a common adverse outcome.
EFSA recognized that this is a conservative assumption and
that refinements may be possible if future research shows
that it can be justified. That means that clear criteria for the
deviation from the assumption of similar MoA and applica-
tion of the principle of independent action and effect/
response addition are needed. However, such criteria for
determining when MoAs of different chemicals are
sufficiently dissimilar to indicate independent action are cur-
rently lacking.
A third scenario is that interactions between mixture com-
ponents cause synergistic or antagonistic effects. Some of
the available guidance discusses methods for risk assessment
of mixtures with interactions between components (US EPA
2000; VKM 2008; IGHRC 2009; ECHA 2015; ATSDR 2018; EFSA
2018a). These are often based on modifications of the HI
methodology by weight-of-evidence evaluation of binary
interaction data (BINWOE method) or by applying an extra
uncertainty factor for possible interactions. The BINWOE
method categorizes, based on qualitative analyses on empir-
ical observations and mechanistic considerations, the most
plausible causes of potential influences of one compound to
the toxicity of another in a mixture, for a given exposure
scenario (Mumtaz and Durkin 1992).
PBPK models may also be useful to examine alterations in
kinetic processes, which may be a mechanism for toxico-
logical interactions between mixture components. However,
several authorities and organizations have concluded that
there is currently little empirical evidence of interactions
occurring between mixture components at (low) dose levels
relevant for dietary exposure scenarios in the general popula-
tion, particularly for regulated chemicals, which are managed
so that individual exposure is below the respective health
based guidance value (EFSA 2008, 2013c, 2015; SCHER/
SCENIHR/SCCS 2012; Moretto et al. 2017). Focus has therefore
been on approaches and methods assuming non-interaction,
i.e. dose addition or response/effect addition.
4. EuroMix contribution to international risk
assessment and testing of mixtures
4.1. Aim of the EuroMix project
EuroMix aims to develop a pragmatic approach for risk
assessment of combined exposure to multiple chemicals
derived from multiple sources. The approach developed will
be assessed in proof-of-principle studies in which the use of
in silico tools and in vitro methods for this purpose will be
verified in vivo for three adverse outcomes (i.e. liver steatosis,
adverse effects on reproduction due to endocrine disruption,
and skeletal malformation/cleft palate), as examples. The
EuroMix project will deliver an innovative platform of tools
and test methods for mixture testing and refined grouping of
chemicals into CAGs, for both data rich and data poor chemi-
cals. Hazard and exposure models will be embedded in a
model toolbox, made available to stakeholders through an
openly accessible web-based platform. Criteria will be set
and guidance will be produced on how to use and imple-
ment the tiered testing and assessment strategy.
Dissemination and harmonization of the approach within EU
and more broadly within the international community, by
involving, among others, WHO, Codex Alimentarius, OECD
and US EPA in the project and by the participation of experts
from such organizations will play a key role in helping estab-
lish international food safety policies.
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4.2. EuroMix contributions to harmonization
During the course of the EuroMix project a series of inter-
national harmonization workshops, with participants from sev-
eral continents and authorities (e.g. Australian Pesticides and
Veterinary Medicines Authority (APVMA), Codex Alimentarius,
EFSA, Food and Agriculture Organization (FAO), JRC, OECD, US
EPA, US FDA, WHO, RIVM, German Federal Institute for Risk
Assessment (BfR)) are being organized. In the first two work-
shops already held, the extent to which risk assessment of
combined exposure to multiple chemicals derived from mul-
tiple sources is harmonized internationally and across regula-
tory sectors and the remaining hurdles that need to be
overcome to achieve further harmonization were identified
(EuroMix 2017). The first workshop was held in London in
October 2016. Experts in risk assessment from different regula-
tory sectors and different regions reviewed approaches being
used to assess risks from combined exposure to multiple
chemicals. Whilst there were broad similarities in the
approaches used, a number of key issues were identified
where there is clearly a lack of harmonization. These include
transparency of problem formulation, the scope of cumulative
risk assessments (which regulatory sector(s) should be cov-
ered), the basis for grouping chemicals into assessment groups
and how information on MoA/AOPs should be taken into
account in such assessments. The second workshop was held
in Brussels, May 2017. Experts in risk assessment met with a
range of risk managers primarily from Europe and North
America, as well as international organizations, to discuss regu-
latory needs in assessing the risks from combined exposure to
multiple chemicals. It was apparent that there is currently no
overarching approach to such assessments, either within the
EU (across regulatory sectors) or internationally. Approaches to
assessing the risks from combined exposure to multiple chemi-
cals vary across regulatory sectors and geographies, sometimes
markedly. In some sectors, assessing the risks from combined
exposure to multiple chemicals is currently not a significant
consideration, whereas in others there is appreciable concern.
However, even in the latter case, approaches utilized in differ-
ent regions show substantial differences. The most common
approach to date for developing cumulative assessment
groups is use of common structure and/or co-occurrence and/
or designed function (e.g. pesticidal mode of action). Work is
underway both within and beyond the EU to explore harmon-
ization of approaches to assessing the risks from combined
exposure to multiple chemicals within and across regulatory
sectors. Future workshops will consider how greater harmon-
ization can be achieved, using in part the results of the
EuroMix project. Whilst it is likely that the approaches used
will vary, depending on problem formulation, it should be pos-
sible to harmonize the scientific principles used and to estab-
lish guidance to ensure greater transparency in reporting the
approaches adopted.
4.3. EuroMix contributions to cumulative
risk assessment
EuroMix aims for a systematic approach to risk assessment of
combined exposure to multiple chemicals by identifying the
appropriate tools for the various tiers. Referring to the issues
of the frameworks discussed in section 3, the outcome of the
EuroMix project will facilitate:
1. Comparison of deterministic (conservative) and probabil-
istic elements in tiered approaches to exposure, hazard
and risk assessment. These tiered approaches will be
made available as part of the web-based data and model
platform MCRA, that will also be used to organize con-
sumption data, residue data and hazard data.
2. Development of a refinement of the current approach
for grouping pesticides into CAGs enabling better use of
MoA/AOP information organized in AOP networks. This
will include methods for an assessment of the likelihood
of independent action as relevant for the studied
adverse outcomes, and the likelihood of synergistic or
antagonistic effects.
3. Reconciliation of potential international differences in
the use of inclusion and exclusion approaches to the cre-
ation of CAGs. Methods for assessing the uncertainties
associated with use of an exclusion approach and an
inclusion approach will be developed and means of
addressing these proposed, for example by using uncer-
tainty factors.
4. Refinement of methods for assessing combined exposure
to chemicals. In considering co-exposure, exposure to
different chemicals may occur simultaneously in time
and source (e.g. pre-formed mixtures), separated by time
(e.g. foods on different days), separated by source (differ-
ent foods or oral vs. dermal exposure) or separated by
both. This will require consideration not only of toxicoki-
netics but also of the persistence and reversibility of the
toxicodynamic response.
5. An overarching approach to risk assessment of com-
bined exposure to multiple chemicals via different routes
of exposure. EFSA is developing a guidance document
for human and ecological risk assessment of combined
exposure to multiple chemicals using existing frame-
works as a starting point and tiered approaches for each
step (problem formulation, hazard identification, hazard
characterization, exposure assessment, risk characteriza-
tion) (EFSA 2018a). EuroMix will determine how its
research outputs can be best integrated into
this framework.
5. Conclusions
5.1. Implementation of risk assessment of combined
exposure to multiple chemicals
Whilst assessment of the risk from combined exposure to
intentional mixtures is mandated by different legislation in
several regulatory sectors in Europe, risk assessment of unin-
tentional mixtures is much less widely required and guidance
has yet to be finalized on how this should be performed.
However, the risk to human health is a consequence of the
totality of exposure and it has been recognized that this will
require cross-sectorial assessments (Evans et al. 2016).
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Even where there is requirement that unintentional mix-
tures should be assessed, such as for pesticide residues, there
are major regional differences in how this is undertaken (e.g.
US EPA compared to EFSA). This may, for example, result in
different acceptability of standards for pesticide residues in
food commodities (e.g. MRLs), with attendant implications
related to different levels of consumer protection, risk com-
munication, and international trade.
From a scientific perspective, the methodology for the
establishment of CAGs should have the flexibility to include
all relevant chemicals to which humans are co-exposed,
regardless of regulatory sector and geographical region.
However, the introduction of a comprehensive and system-
atic approach to risk assessment of combined exposure to
multiple chemicals will be complex and has many practical
and regulatory implications. Hence, a step-wise approach
would be more pragmatic and feasible. There is agreement
that detailed information on MoAs/AOPs should be utilized in
creation and/or refinement of CAGs. However, clarity is
needed on how such information will be obtained and uti-
lized. The default assumption for members of a CAG is
dose addition.
While the current scientific approaches summarized here
represent a broad application of knowledge and integrated
methods to address the challenges of risk assessment of
combined exposure to multiple chemicals, additional guid-
ance and harmonized method development will increase
transparency and structure, as well as improve confidence in
risk assessment conclusions. A review of existing legislation
and discussions with risk assessors and risk managers has
clearly established that no single approach will be applicable
in the short to medium term. The approach adopted is as
much a policy decision as a scientific one, and should be
clearly reflected in problem formulation. Hence, EuroMix is
developing an integrated testing and assessment strategy
using a range of in vitro and in silico tests, appropriate to the
tier of the assessment, together with more appropriate data
on potential cumulative effects which can be combined in a
scientifically-based weight of evidence approach to account
for complexity, address uncertainty and improve
risk assessment.
5.2. Further research and development needs
The current review highlighted the following needs in
research and development:
 Development of structured and flexible approaches and
harmonized guidance for grouping chemicals into refined
and relevant assessment groups;
 Establishing criteria for determining when substances
have dissimilar MoAs/AOPs and deviate from the default
assumption of dose addition;
 Development of guidance on how to apply an integrated
testing and assessment strategy using alternative meth-
odology and non-animal data, e.g. for strategies for
refined grouping and for determining RPFs;
 Development of structured approaches for collecting
data from exposure to multiple substances, either simul-
taneously or in sequence, for use in risk assessment of
combined exposure to multiple chemicals;
 Development of guidance for analyzing uncertainties
associated with risk assessment of combined exposure to
multiple chemicals, e.g. uncertainties associated with the
grouping of chemicals into assessment groups and
assumptions concerning similar MoAs/AOPs and applica-
tion of dose addition.
In addition, practical guidance for problem formulation in
cumulative risk assessment is needed (Solomon et al. 2016).
The problem formulation step is critical for structuring the
risk assessment by specifying the purpose and scope of the
assessment, including e.g. prioritization of chemicals, expos-
ure pathways and endpoints, as well as the approach to be
taken, analytical needs, available resources and the level of
complexity of the assessment.
The OECD and EFSA have identified the development of
harmonized methodologies for combined exposure to mul-
tiple chemicals as a key priority area and initiated a number
of activities. EFSA is currently working on a guidance docu-
ment addressing a harmonized framework for risk assessment
of combined exposure to multiple chemicals, which is based
on the stepwise approaches for problem formulation, expos-
ure assessment, hazard assessment, risk characterization and
uncertainty analysis combined with the principle of tiering
(EFSA 2018a). Recently, the representatives of several EC
funded research projects (EDC-MixRisk, EuroMix, EU-ToxRisk,
HBM4EU, SOLUTIONS), have sent a position paper to the EU
Commission, proposing 12 key actions and recommendations
to help better address combined effects and overcome
remaining gaps in chemical mixture research (Altenburger
et al. 2018). Contributing to the further development of inter-
nationally harmonized approaches for risk assessment of
combined exposures to multiple chemicals is also the overall
goal of the Horizon 2020 project “EuroMix”.
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